IN2014CN04809A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04809A IN2014CN04809A IN4809CHN2014A IN2014CN04809A IN 2014CN04809 A IN2014CN04809 A IN 2014CN04809A IN 4809CHN2014 A IN4809CHN2014 A IN 4809CHN2014A IN 2014CN04809 A IN2014CN04809 A IN 2014CN04809A
- Authority
- IN
- India
- Prior art keywords
- tbut
- prolongs
- treatment
- disclosed
- dry eye
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A salt free emulsion for the treatment of dry eye and other ocular conditions is disclosed which contains castor oil and does not contain olive oil which prolongs TBUT and provides superior comfort.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161568089P | 2011-12-07 | 2011-12-07 | |
US201261625401P | 2012-04-17 | 2012-04-17 | |
PCT/US2012/068615 WO2013086449A1 (en) | 2011-12-07 | 2012-12-07 | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN04809A true IN2014CN04809A (en) | 2015-09-18 |
Family
ID=47459152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN4809CHN2014 IN2014CN04809A (en) | 2011-12-07 | 2012-12-07 |
Country Status (28)
Country | Link |
---|---|
US (2) | US9314528B2 (en) |
EP (4) | EP3981387A1 (en) |
JP (1) | JP6142419B2 (en) |
KR (1) | KR102017922B1 (en) |
CN (2) | CN104114152A (en) |
AR (1) | AR089123A1 (en) |
AU (2) | AU2012347459A1 (en) |
BR (1) | BR112014013820A8 (en) |
CA (1) | CA2858574C (en) |
CL (1) | CL2014001518A1 (en) |
CO (1) | CO6990739A2 (en) |
DK (2) | DK2787969T3 (en) |
ES (2) | ES2896336T3 (en) |
HK (2) | HK1201458A1 (en) |
HU (2) | HUE049489T2 (en) |
IL (1) | IL233008A (en) |
IN (1) | IN2014CN04809A (en) |
MX (1) | MX355216B (en) |
MY (1) | MY173378A (en) |
PH (1) | PH12014501296A1 (en) |
PL (2) | PL2787969T3 (en) |
PT (2) | PT2787968T (en) |
RU (1) | RU2014127074A (en) |
SG (1) | SG11201403013VA (en) |
SI (2) | SI2787969T1 (en) |
TW (1) | TWI652072B (en) |
WO (2) | WO2013086449A1 (en) |
ZA (1) | ZA201404228B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
US9907826B2 (en) | 2011-12-07 | 2018-03-06 | Allergan, Inc. | Efficient lipid delivery to human tear film using a salt-sensitive emulsion system |
ES2706535T3 (en) | 2016-07-07 | 2019-03-29 | Salvat Lab Sa | Ophthalmic compositions comprising castor oil and medium chain triglycerides |
EP3500344A4 (en) | 2016-08-19 | 2020-08-05 | Akrivista, LLC | Methods of diagnosing and treating dry eye syndrome and compositions for treating a human eye |
CN111295169A (en) | 2017-08-18 | 2020-06-16 | 阿克里维斯塔有限责任公司 | Methods of diagnosing and treating dry eye syndrome and compositions for treating human eyes |
US11096958B2 (en) | 2018-04-27 | 2021-08-24 | Allergan, Inc. | Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201706A (en) | 1978-09-22 | 1980-05-06 | Burton, Parsons & Company, Inc. | Treatment of corneal edema |
DE3066859D1 (en) * | 1979-10-26 | 1984-04-12 | Smith & Nephew Ass | Autoclavable emulsions |
US5192535A (en) | 1988-02-08 | 1993-03-09 | Insite Vision Incorporated | Ophthalmic suspensions |
IT1224795B (en) | 1988-12-01 | 1990-10-24 | Sigma Tau Ind Farmaceuti | USE OF ACETYL D-CARNITINE IN THE THERAPEUTIC TREATMENT OF GLAUCOMA AND PHARMACEUTICAL COMPOSITIONS USEFUL IN SUCH TREATMENT |
ES2038580T3 (en) | 1989-08-03 | 1994-10-16 | Eisai Co Ltd | PHOTOSTABILIZATION METHOD OF OPHTHALMIC SOLUTIONS. |
US5681555A (en) | 1991-04-22 | 1997-10-28 | Gleich; Gerald J. | Method for the treatment of bronchial asthma by parenteral administration of anionic polymers |
DE4229494A1 (en) | 1992-09-04 | 1994-03-10 | Basotherm Gmbh | Medicines for topical use on the eye to treat increased intraocular pressure |
CA2199610A1 (en) | 1994-09-14 | 1996-03-21 | Taisho Pharmaceutical Co., Ltd. | Eye drops for repairing repairing corneal damage |
US5980865A (en) | 1995-08-18 | 1999-11-09 | Baker Norton Pharmaceuticals, Inc. | Method for treating late phase allergic reactions and inflammatory diseases |
FI106923B (en) | 1997-01-03 | 2001-05-15 | Cultor Ltd Finnsugar Bioproduc | Use of trimethylglycine in preparations for hygiene and care of the mucous membranes of the body |
AR002194A1 (en) | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | COMPUTERIZED INSTRUMENT FOR THE ANALYSIS OF MOVEMENT. |
IT1302307B1 (en) | 1998-09-01 | 2000-09-05 | Sigma Tau Healthscience Spa | COMPOSITION WITH ANTIOXIDANT ACTIVITY AND FOR IMPROVING THE METABOLIC USE OF GLUCOSE, INCLUDING ACETYL |
ES2228128T3 (en) | 1998-11-13 | 2005-04-01 | Continental Projects Limited | HIALURONIC ACID COMPLEX / CARNITINE AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS. |
JP2000159659A (en) * | 1998-11-30 | 2000-06-13 | Kazuo Tsubota | Artificial lachrymal fluid for ophthalmology |
US6228392B1 (en) | 1999-04-29 | 2001-05-08 | Gene Tools, Llc | Osmotic delivery composition, solution, and method |
RU2291685C2 (en) | 2000-07-14 | 2007-01-20 | Аллерган Инк. | Composition containing therapeutically active ingredients having increased solubility |
CA2355814C (en) | 2000-09-14 | 2010-06-29 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Pharmaceutical composition for ophthalmic use |
AU2720602A (en) | 2000-11-08 | 2002-05-21 | Bio Concept Lab | Improved ophthalmic and contact lens solutions containing simple saccharides as preservative enhancers |
US7045121B2 (en) | 2001-12-14 | 2006-05-16 | Allergan, Inc. | Ophthalmic compositions for lubricating eyes and methods for making and using same |
WO2004028536A1 (en) | 2002-09-30 | 2004-04-08 | Babizhayev Mark A | Method for topical treatment of eye disease and composition and device for said treatment |
WO2004035005A2 (en) * | 2002-10-18 | 2004-04-29 | Echols Joel S | Three layer tear formulation |
US20040137079A1 (en) | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
US6635654B1 (en) * | 2003-01-09 | 2003-10-21 | Allergan, Inc. | Ophthalmic compositions containing loratadine |
WO2004084877A1 (en) | 2003-03-26 | 2004-10-07 | Menicon Co., Ltd. | Composition for ophthalmic use |
TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
JP4860475B2 (en) * | 2003-06-13 | 2012-01-25 | アルコン,インコーポレイテッド | Ophthalmic composition comprising a synergistic combination of two polymers |
US20050009836A1 (en) | 2003-06-26 | 2005-01-13 | Laskar Paul A. | Ophthalmic composition containing quinolones and method of use |
CA2549737A1 (en) * | 2003-11-10 | 2005-05-26 | Toray Industries, Inc. | Polysaccharide-containing composition and tear film stabilizing ophthalmic solution |
US8569367B2 (en) * | 2004-11-16 | 2013-10-29 | Allergan, Inc. | Ophthalmic compositions and methods for treating eyes |
US7288520B2 (en) * | 2005-07-13 | 2007-10-30 | Allergan, Inc. | Cyclosporin compositions |
US9561178B2 (en) * | 2006-07-25 | 2017-02-07 | Allergan, Inc. | Cyclosporin compositions |
WO2008035246A2 (en) * | 2006-07-28 | 2008-03-27 | Novagali Pharma Sa | Compositions containing quaternary ammonium compounds |
CN101896160A (en) * | 2006-10-17 | 2010-11-24 | 阿勒根公司 | Cyclosporin compositions |
CA2679448A1 (en) | 2007-02-28 | 2008-09-04 | Aciex, Inc. | Methods and compositions for normalizing meibomian gland secretions |
JP4929245B2 (en) | 2008-07-31 | 2012-05-09 | 株式会社ベッセル工業 | Tool grip |
WO2010141648A2 (en) * | 2009-06-05 | 2010-12-09 | Allergan, Inc. | Artificial tears and therapeutic uses |
US8957048B2 (en) * | 2011-10-06 | 2015-02-17 | Allergan, Inc. | Compositions for the treatment of dry eye |
-
2012
- 2012-12-07 PL PL12808607T patent/PL2787969T3/en unknown
- 2012-12-07 ES ES12808607T patent/ES2896336T3/en active Active
- 2012-12-07 ES ES12808606T patent/ES2797650T3/en active Active
- 2012-12-07 JP JP2014546154A patent/JP6142419B2/en active Active
- 2012-12-07 RU RU2014127074A patent/RU2014127074A/en unknown
- 2012-12-07 SI SI201231957T patent/SI2787969T1/en unknown
- 2012-12-07 EP EP21198843.1A patent/EP3981387A1/en active Pending
- 2012-12-07 TW TW101146304A patent/TWI652072B/en active
- 2012-12-07 MY MYPI2014001672A patent/MY173378A/en unknown
- 2012-12-07 EP EP12808606.3A patent/EP2787968B1/en active Active
- 2012-12-07 AU AU2012347459A patent/AU2012347459A1/en not_active Abandoned
- 2012-12-07 WO PCT/US2012/068615 patent/WO2013086449A1/en active Application Filing
- 2012-12-07 KR KR1020147018598A patent/KR102017922B1/en active IP Right Grant
- 2012-12-07 MX MX2014006804A patent/MX355216B/en active IP Right Grant
- 2012-12-07 WO PCT/US2012/068603 patent/WO2013086438A1/en active Application Filing
- 2012-12-07 US US13/708,771 patent/US9314528B2/en active Active
- 2012-12-07 EP EP20153344.5A patent/EP3666257A1/en active Pending
- 2012-12-07 PT PT128086063T patent/PT2787968T/en unknown
- 2012-12-07 BR BR112014013820A patent/BR112014013820A8/en not_active Application Discontinuation
- 2012-12-07 PL PL12808606T patent/PL2787968T3/en unknown
- 2012-12-07 US US13/708,783 patent/US20130150324A1/en not_active Abandoned
- 2012-12-07 SG SG11201403013VA patent/SG11201403013VA/en unknown
- 2012-12-07 HU HUE12808606A patent/HUE049489T2/en unknown
- 2012-12-07 EP EP12808607.1A patent/EP2787969B1/en active Active
- 2012-12-07 HU HUE12808607A patent/HUE057140T2/en unknown
- 2012-12-07 IN IN4809CHN2014 patent/IN2014CN04809A/en unknown
- 2012-12-07 DK DK12808607.1T patent/DK2787969T3/en active
- 2012-12-07 CN CN201280067685.0A patent/CN104114152A/en active Pending
- 2012-12-07 AR ARP120104614A patent/AR089123A1/en not_active Application Discontinuation
- 2012-12-07 SI SI201231783T patent/SI2787968T1/en unknown
- 2012-12-07 CN CN201810890387.0A patent/CN108969482A/en active Pending
- 2012-12-07 DK DK12808606.3T patent/DK2787968T3/en active
- 2012-12-07 CA CA2858574A patent/CA2858574C/en active Active
- 2012-12-07 PT PT128086071T patent/PT2787969T/en unknown
-
2014
- 2014-06-06 PH PH12014501296A patent/PH12014501296A1/en unknown
- 2014-06-08 IL IL233008A patent/IL233008A/en active IP Right Grant
- 2014-06-09 CL CL2014001518A patent/CL2014001518A1/en unknown
- 2014-06-09 ZA ZA2014/04228A patent/ZA201404228B/en unknown
- 2014-06-26 CO CO14138315A patent/CO6990739A2/en unknown
-
2015
- 2015-02-27 HK HK15102023.0A patent/HK1201458A1/en unknown
- 2015-04-14 HK HK15103604.5A patent/HK1203057A1/en unknown
-
2017
- 2017-11-27 AU AU2017265181A patent/AU2017265181B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY171920A (en) | Prevention and treatment of ocular conditions | |
HK1222116A1 (en) | Drain valve implantable in the eye of a patient for the treatment of glaucoma | |
HRP20130830T1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
PH12019501902A1 (en) | Ocular formulations for drug-delivery to the posterior segment of the eye | |
MX362185B (en) | Compositions and treatment for eye diseases and disorders. | |
IN2014CN04809A (en) | ||
HK1201438A1 (en) | Treatment of ocular disease | |
IN2014CN03123A (en) | ||
MX2014000781A (en) | Fixed dose combination of bimatoprost and brimonidine. | |
HK1186660A1 (en) | A water-in-oil type emulsion for treating a disease of the eye | |
EP3013425A4 (en) | Treatment and diagnosis of ocular disease | |
UY34843A (en) | TREATMENT OF OCULAR INFLAMMATORY DISEASES USING LAQUINIMOD | |
EP3182952A4 (en) | Modifying humidity to glabrous tissue for the treatment of migraine and other conditions | |
EP3145532A4 (en) | Individualized treatment of eye disease | |
HK1220144A1 (en) | Use of n-(4-tert-butylbenzyl)-3-chloro-n-[2-(4-chloro-3-ethyl- phenyl)-ethyl]-2-fluoro- 5-trifluoromethyl-benzamide for the treatment of eye diseases n-(4--)-3--n-[2-(4--3--)-]-2--5-- | |
PH12015501211A1 (en) | Use of pidotimod to treat atopic dermatitis | |
MX2016005505A (en) | Cetp modulator for use in the treatment of eye disease. | |
HK1216233A1 (en) | Agent for preventing or treating diseases of posterior part of the eye and containing tetrahydropyranyl amino cyclopentylcarbonyl tetrahydropyridopyridine derivative as active component | |
UA113065C2 (en) | SKIN COMPOSITION AND APPLICATION | |
UA111645C2 (en) | EFFICIENT DELIVERY OF LIPIDES INTO THE TREATMENT OF HUMAN FILM USING THE SALT-EMULSIVE SYSTEM | |
PL401911A1 (en) | Use of the preparation with the immunoregulatory properties | |
CN302327175S (en) | glasses | |
MX2013006527A (en) | Arylsulfonamide derivatives for the prevention or treatment of specific ophthalmologic disorders. |